OTC Markets OTCPK - Delayed Quote USD

Trevena, Inc. (TRVN)

1.2200
+0.0700
+(6.09%)
As of 9:51:03 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
546
--
-418
567
3,069
Cost of Revenue
1,586
--
3,018
954
182
Gross Profit
-1,040
--
-3,436
-387
2,887
Operating Expense
31,065
--
52,939
51,538
32,372
Operating Income
-32,105
--
-56,375
-51,925
-29,485
Net Non Operating Interest Income Expense
-1,711
--
-805
161
211
Other Income Expense
-141
--
3,510
176
205
Pretax Income
-33,957
--
-53,670
-51,588
-29,069
Tax Provision
79
--
--
0
300
Net Income Common Stockholders
-34,036
--
-53,670
-51,588
-29,369
Diluted NI Available to Com Stockholders
-34,036
--
-53,670
-51,588
-29,369
Basic EPS
-48.89
-79.00
-189.75
-200.00
-143.75
Diluted EPS
-48.89
-79.00
-189.75
-200.00
-143.75
Basic Average Shares
796.7280
509.4000
282.8940
261.2690
204.1980
Diluted Average Shares
796.7280
509.4000
282.8940
261.2690
204.1980
Total Operating Income as Reported
-32,105
--
-56,375
-51,925
-29,485
Total Expenses
32,651
--
55,957
52,492
32,554
Net Income from Continuing & Discontinued Operation
-34,036
--
-53,670
-51,588
-29,369
Normalized Income
-37,475.6600
--
-64,861
-51,592
-29,368.2700
Interest Income
1,190
--
451
162
240
Interest Expense
2,901
--
1,256
1
29
Net Interest Income
-1,711
--
-805
161
211
EBIT
-31,056
--
-52,414
-51,587
-29,040
EBITDA
-30,699
--
-52,032
-51,159
-28,563
Reconciled Cost of Revenue
1,586
--
3,018
954
182
Reconciled Depreciation
357
--
382
428
477
Net Income from Continuing Operation Net Minority Interest
-34,036
--
-53,670
-51,588
-29,369
Total Unusual Items Excluding Goodwill
4,354
--
11,191
4
-1
Total Unusual Items
4,354
--
11,191
4
-1
Normalized EBITDA
-35,053
--
-63,223
-51,163
-28,562
Tax Rate for Calcs
0.0002
--
0
0
0.0003
Tax Effect of Unusual Items
914.3400
--
0
0
-0.2700
12/31/2020 - 1/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
 
MTEM Molecular Templates, Inc.
0.0001
0.00%
 
CLRB Cellectar Biosciences, Inc.
0.2510
-0.20%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
IPHA Innate Pharma S.A.
2.5139
+5.63%
 
LPCN Lipocine Inc.
3.2950
-1.05%
 
RLYB Rallybio Corporation
0.3148
+7.44%
 
RGBP Regen BioPharma, Inc.
0.0580
0.00%
 
ENSC Ensysce Biosciences, Inc.
2.1700
+4.33%
 
NERV Minerva Neurosciences, Inc.
1.5900
-1.85%